In the later stages of tumorigenesis, TGF-β acts as a tumor stimulator, thereby promoting cellular changes associated with migration, invasion and metastasis, immunosuppression, angiogenesis, myofibroblast generation, interaction between cancer cells, extracellular matrix and EMT [26] (Figure 1). The gene discussed is TGFB1; the disease is neoplasm.